|
|
Volumn 161, Issue 9, 2004, Pages 1717-1718
|
|
Practice guidelines and combining atypical antipsychotics [5]
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
CLOZAPINE;
AGRANULOCYTOSIS;
DRUG CHOICE;
DRUG INDICATION;
DRUG SAFETY;
HUMAN;
LETHARGY;
LETTER;
MEDICAL SOCIETY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
RISK ASSESSMENT;
SCHIZOPHRENIA;
SEIZURE;
SIDE EFFECT;
WEIGHT GAIN;
ANTIPSYCHOTIC AGENTS;
CLOZAPINE;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
HUMANS;
MANAGED CARE PROGRAMS;
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES;
PSYCHIATRY;
SCHIZOPHRENIA;
SOCIETIES, MEDICAL;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 4444350821
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.161.9.1717 Document Type: Letter |
|
Times cited : (6)
|
|
References (3)
|
